Chartered Management Institute

FEBRUARY 26, 2024

Since founding the Human Diver in 2016, Gareth has given risk training to a wide variety of organisations, from oil and gas and construction to pharmaceuticals and software. In all sectors, tensions exist between competing pressures such as resources, finance, time and workload.

Uncertainty 52

Uncertainty Risk Management Training Compliance 52

Harvard Business Review

MARCH 14, 2017

In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.

Innovation 9

Innovation Company Incentives Industry 9

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Finance Innovation' Executing on Innovation An HBR Insight Center. Innovation Isn''t an Idea Problem.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Finance Innovation Insight Center_Innovation no-intromercial' Innovation Isn’t an Idea Problem.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

AUGUST 6, 2015

I made a career switch seven years ago, when I went from working as a reporter at the Financial Times , where I covered health care in the United States, to consulting — advising CEOs in the pharmaceutical industry on thought leadership and articulating their corporate strategies. Consider the legal field.

Career 8

Career Skills Health Care Pharmaceuticals 8

Harvard Business Review

AUGUST 23, 2018

For example, Boston’s program includes job placements at private-sector employers across a wide range of industries, including finance, health care, life sciences, and education.

Short-term 8

Short-term Participative Long-term Career 8

Harvard Business Review

FEBRUARY 26, 2013

But when leaders take this conservative growth approach even when there is reasonable certainty of success and available financing, they undersize their sales forces and forfeit opportunity. An "earn-your-way" strategy is sometimes necessary in markets with high uncertainty or when a company is cash-strapped. A Better Approach.

Company 8

Company Short-term Long-term Cost 8

Harvard Business Review

SEPTEMBER 13, 2011

After all, positive results attract investors, raise stock prices, reinforce customers, draw talent, and more. Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

JANUARY 26, 2011

The SSE is well positioned to do so because the exchange has already taken a number of steps to improve reporting on nonfinancial (i.e., Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology.

Long-term 15

Long-term Sample Report Pharmaceuticals 15

Harvard Business Review

MAY 5, 2016

sanctions are delaying these projects being financed. And Danish pharmaceutical company Novo Nordisk is building on its Iran presence by doubling local staff to nearly 300 and investing $76 million in a new factory. Otherwise, companies risk facing challenges related to pricing, value, and positioning against competitors.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

FEBRUARY 24, 2015

But a study from 1999 found that long-run performance of both the former parent company and the divested unit is strongly positive, provided that the spin-off increases the company’s focus. The outsiders provide new blood in support functions such as finance, legal, or administration.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

FEBRUARY 4, 2013

Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance. Breakthrough is about the establishment of new models that better account for businesses' negative (and positive) externalities. "We Breakthrough Access. Breakthrough involves a shift to new types of impact investment.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

MARCH 6, 2014

Indeed, should this have not crossed your mind, the PLoS authors tie their findings to past behavior by the tobacco and pharmaceutical industries. In fact, the four systematic reviews from 2012 onwards all found mostly positive associations; none were funded by industry. Yes/no; positive association?

Peer Review 8

Peer Review Review Industry Wilde 8

Harvard Business Review

JANUARY 26, 2016

And yet for almost every company that uses CI in their decision-making, there’s another that disregards CI’s mix of industry analysis, rival positions, and market insight to their detriment. and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8